Authors: SCHONDORF T ENGEL H KURBACHER CM BRENNE U KOLHAGEN H GOHRING UJ SCHARL A MALLMANN P

Citation: T. Schondorf et al., IMMUNOLOGICAL FEATURES OF TUMOR-INFILTRATING LYMPHOCYTES AND PERIPHERAL-BLOOD LYMPHOCYTES IN OVARIAN-CANCER PATIENTS, Journal of the Society for Gynecologic Investigation, 5(2), 1998, pp. 102-107

Authors: KURBACHER CM CREE IA BRUCKNER HW BRENNE U KURBACHER JA MULLER K ACKERMANN T GILSTER TJ WILHELM LM ENGEL H MALLMANN PK ANDREOTTI PE

Citation: Cm. Kurbacher et al., USE OF AN EX-VIVO ATP LUMINESCENCE ASSAY TO DIRECT CHEMOTHERAPY FOR RECURRENT OVARIAN-CANCER, Anti-cancer drugs, 9(1), 1998, pp. 51-57

Authors: KURBACHER CM MUNSCH S BRENNE U GILSTER T MALLMANN P BRUCKNER HW

Citation: Cm. Kurbacher et al., DOSE-RESPONSE IN PRIMARY OVARIAN-CANCER EVALUATED BY AN EX-VIVO ATP CHEMOSENSITIVITY ASSAY, European journal of cancer, 33, 1997, pp. 539-539

Authors: KURBACHER CM CREE IA BRENNE U BRUCKNER HW KURBACHER JA MALLMANN P ANDREOTTI PE KREBS D

Citation: Cm. Kurbacher et al., HETEROGENEITY OF IN-VITRO CHEMOSENSITIVITY IN PERIOPERATIVE BREAST-CANCER CELLS TO MITOXANTRONE VERSUS DOXORUBICIN EVALUATED BY A MICROPLATE ATP BIOLUMINESCENCE ASSAY, Breast cancer research and treatment, 41(2), 1996, pp. 161-170

Authors: LEE JM BRUCKNER HW SZRAJER L BRENNE U SCHINDELHEIM G ANDREOTTI PE

Citation: Jm. Lee et al., TAXOL INHIBITS GROWTH OF MESOTHELIOMA XENOGRAFTS, Anticancer research, 15(3), 1995, pp. 693-696